Comparative activities in vitro of augmentin (amoxycillin/clavulanic acid) and oral cephalosporins.
Griffin
K E
KE
Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey, England.
Cooper
C E
CE
Slocombe
B
B
D000658:Amoxicillin / Q000494:pharmacology*; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001768:Blister / Q000382:microbiology; D002511:Cephalosporins / Q000494:pharmacology*; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008826:Microbial Sensitivity Tests
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin